Skip to main content

CON-TGO91-285 - Novartis Pharmaceuticals Australia Pty Ltd

Product names
  • ARTG 169890 - GILENYA fingolimod (as hydrochloride) 0.5 mg capsule blister pack - pack of 7 capsules
Decision Date
Duration
The consent is effective for all batches manufactured between 1 September 2020 and 30 April 2021.
Non-compliance with standard

The product(s) do not conform with the requirements of TGO 91 but are supplied with label(s) that have been approved by the TGA.

Supply/Import or Export
Supply
Therapeutic good type
Prescription medicines

Help us improve the Therapeutic Goods Administration site